AN1 0.00% 0.8¢ anagenics limited

Quarterly Trends, page-7

  1. 1,762 Posts.
    lightbulb Created with Sketch. 3064
    Excellent 4Q16 results. The updated charts below tell the story.

    Operational expenses are markedly down apart from staff expenses, which has seen a one-off increase due to the change from a contract team to the Company’s own sales force. The significant improvement in sell-through to pharmacies is important.

    Some serious cash is beginning to flow in, with receipts more than double that of the previous quarter and at 270% compared with a year ago. The FY2016 figure of $3.89M cash receipts is up 248% compared with FY2015.

    Net cash outflow for the quarter of $232K is excellent. Previous quarters have averaged a little over $1M in operational cash burn. This has resulted in only a minor change in cash held at the end of the quarter.

    Japan already profitable.

    There appears to be is every chance of achieving a cash flow positive position by the end of 2016.


    4Q16 Cash Receipts.JPG
    4Q16 Expenses A.JPG
    4Q16 Expenses B.JPG
    4Q16 Cash Held.JPG


 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 16.12pm 16/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.